Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Pathogens and Global Health|March 7, 2022
Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in ItalyGiuseppina Brancaccio, Milensu Shanyinde, Massimo Puoti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) studyEllen Tedaldi, Lars Peters, Jacquie Neuhaus, et al.
International Journal of STD & AIDS|January 20, 2025
Increasing incidence of <i>Mycoplasma genitalium</i> is driven by people living with HIV and PrEP usersRoberto Rossotti, Alice Nava, Federico D'Amico, et al.
Open Forum Infectious Diseases|June 7, 2017
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus InfectionGiovanni Guaraldi, Roberto Rossotti, Gabriella Verucchi, et al.
BMC Public Health|October 17, 2019
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?Milensu Shanyinde, Enrico Girardi, Massimo Puoti, et al.
HIV Medicine|January 24, 2024
Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir-based dual combinationsRoberto Rossotti, Federico D'Amico, Nicholas Brian Bana, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2020
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumabAndrea Lauterio, Mila Valsecchi, Sara Santambrogio, et al.
Journal of Hepatology|June 22, 2002
Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)Claudio Puoti, Roberto Castellacci, Fabrizio Montagnese, et al.
Antiviral Therapy|August 6, 2011
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study, Lars Peters, Jacqueline Neuhaus, et al.
Plos One|December 8, 2015
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C VirusCristina Mussini, Patrizia Lorenzini, Massimo Puoti, et al.
Pageof 24